CRP CP2714
CRP CP2714 is a medical device (FDA Class II; FDA product code DCK, C-Reactive Protein, Antigen, Antiserum, And Control) made by Randox Laboratories, Ltd., cleared under FDA 510(k) K954447 on 18 Dec 1995 and listed in FDA GUDID since 16 Sep 2016 (UDI-DI 05055273201741), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05055273201741 | Date16 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK954447 | Date18 Dec 1995 | StatusActive |
Official records
- AccessGUDID record 05055273201741
- FDA 510(k) database K954447
From the FDA record
- Device description
- The device is a latex agglutination slide test intended for qualitative and semi-quantitative in vitro diagnostic determination of C-Reactive Protein (CRP) concentration in serum.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K954447 decided 18 Dec 1995 Active
- FDA GUDID UDI-DI 05055273201741 listed 16 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K954447
- Listed FDA GUDID 05055273201741
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Crp
- Generic name
- C-reactive protein (CRP) IVD, reagent
- Model / Ref / Catalog
- CP2714
- Primary DI / UDI-DI
- 05055273201741
- 510(k) Number
- FDA product code
- DCK
- GMDN term
- C-reactive protein (CRP) IVD, reagent
- Device class
- Class II
- Regulation number
- 866.5270
- GUDID distribution status
- In Commercial Distribution